IL-6 regulates many pathways involved in the acute phase response and adaptive immunity [13], and can be a marker of COPD progression [14,15,16], especially when persistently elevated in people with otherwise stable disease [15]. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.